Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of Multiple Sclerosis Patient Survival Report 2018

Objective: The prevalence of multiple sclerosis (MS) in China is low, although it has been increasing recently. Owing to the paucity of data on immunotherapy acceptance in the Chinese population, we conducted this study to analyze factors affecting the acceptance of immunotherapy and selection of di...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ran, Zeng, Qiuming, Yang, Huan, Xu, Yan, Tan, Guojun, Liu, Hongbo, Wang, Lihua, Zhou, Hongyu, Zhang, Meini, Feng, Jinzhou, Jin, Tao, Zhang, Xinghu, Wang, Jiawei, Zhang, Xu, Gao, Feng, Yang, Chunsheng, Bu, Bitao, Li, Chunyang, Zhang, Min, Dong, Huiqing, Lin, Aiyu, Liu, Weibin, Wu, Lei, Wang, Manxia, Tang, Yulan, Wang, Honghao, Long, Youming, Wang, Zhe, Zheng, Weihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060470/
https://www.ncbi.nlm.nih.gov/pubmed/33897605
http://dx.doi.org/10.3389/fneur.2021.651511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060470/
https://www.ncbi.nlm.nih.gov/pubmed/33897605
http://dx.doi.org/10.3389/fneur.2021.651511

Ejemplares similares